|
|
Resources
Corporate| Regulatory Bodies & Rulings |
Aurobindo gets US nod for drug (November 13, 2009)
Ranbaxy’s AIDS drug gets WHO nod (November 13, 2009)
US nod for Aurobindo drugs (November 10, 2009)
Zenotech gets CLB nod to call for board meeting (November 02, 2009)
S. Africa nod for Aurobindo drugs (October 30, 2009)
Apollo Pharma to retail H1N1 drug (October 21, 2009)
Govt mulls regulator for ‘insolvency professionals’ (October 10, 2009)
No local office for now, says UK healthcare regulator (September 18, 2009)
US nod for Orchid’s drug (September 17, 2009)
US nod for Dr Reddy’s diabetes drug (September 15, 2009)
Mylan drug application (September 15, 2009)
Swiss nod for 2 Aurobindo drugs (September 08, 2009)
USFDA nod for Ranbaxy ulcer drug (August 25, 2009)
RIL open to D6 block auditing (August 19, 2009)
Ranbaxy’s anti-migraine drug gets USFDA nod (August 12, 2009)
Aurobindo relaxants get US nod (August 08, 2009)
Polymed gets US nod for 6 products (August 04, 2009)
SAT appoints Deloitte to ‘re-value’ Dunlop (July 21, 2009)
CLB allows withdrawal of 4 Govt nominees from Mahindra Satyam (July 18, 2009)
Cipla gets notices for alleged overcharging (July 10, 2009)
Lupin, 2 others face Europe anti-trust probe (July 10, 2009)
Jubilant recalls hypertension drug from UK on regulator order (July 03, 2009)
Dr Reddy’s new drug gets nod (June 10, 2009)
Zydus moves DCGI for new diabetes, obesity drug (June 07, 2009)
MNC units abroad to come under drug regulator scanner (May 18, 2009)
Suven Life unit gets USFDA nod (May 07, 2009)
Jubilant gets US FDA nod to market generic Sestamibi (May 05, 2009)
Swiss approval for Aurobindo drug (April 09, 2009)
Zydus files new drug application with USFDA (April 05, 2009)
USFDA nod for Aurobindo AIDS drug (April 01, 2009)
Ranbaxy gets USFDA nod for anti-seizure drug (March 31, 2009)
DoT seeks Finance Ministry’s views on stake sale by new telecom cos (March 30, 2009)
Strides Arcolab gets USFDA nod (March 29, 2009)
Ranbaxy facility gets UK, Australian clearance (March 24, 2009)
US FDA nod for Aurobindo drug (March 21, 2009)
Aurobindo gets nod for HIV drug (March 13, 2009)
Ranbaxy gets USFDA nod for heart drug (March 10, 2009)
Ranbaxy to sell anti-fungal drug in Australia (March 07, 2009)
Ranbaxy gets USFDA nod for BP drug (March 06, 2009)
Aurobindo drug gets US FDA nod (March 05, 2009)
Zydus unit gets accreditation (March 05, 2009)
USFDA action against Ranbaxy based on false drug stability data (February 28, 2009)
Maytas Infra: CLB to appoint 4 more directors including Chairman (February 28, 2009)
US regulator’s action sends Ranbaxy share tumbling 18% (February 27, 2009)
USFDA move on Ranbaxy will have serious implications (February 27, 2009)
39 drug firms under NPPA scanner for overcharging (February 25, 2009)
Aurobindo gets nod for HIV drug (February 21, 2009)
ICAI panel pulls up auditor in GTB case (February 10, 2009)
Zydus gets new approvals (January 31, 2009)
Tanfac wins tariff case (January 14, 2009)
RoC teams pouring over Satyam books (January 11, 2009)
Aurobindo gets nod for epilepsy drug (January 07, 2009)
Transgene Biotek gets licence (January 03, 2009)
Aurobindo gets FDA approval for new drug (January 01, 2009)
Year : 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
|
|
RSS Feeds